Spironolactone use and higher hospital readmission for medicare beneficiaries with heart failure, left ventricular ejection fraction <45%, and estimated glomerular filtration rate <45 ml/min/1.73 m2

American Journal of Cardiology

Volumn 114, Issue 1, 2014, Pages 79-82

  Inampudi, Chakradhari ^a   Parvataneni, Sridivya ^b   Morgan, Charity J ^b   Deedwania, Prakash ^c   Fonarow, Gregg C ^d   Sanders, Paul W ^b,e   Prabhu, Sumanth D ^b,e   Butler, Javed ^f   Forman, Daniel E ^g   Aronow, Wilbert S ^h   Allman, Richard M ⁱ   Ahmed, Ali ^b,e  

^a UNIVERSITY OF IOWA   (United States)

^b UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e BIRMINGHAM VA MEDICAL CENTER   (United States)

^f EMORY UNIVERSITY   (United States)

^g HARVARD UNIVERSITY   (United States)

^h NEW YORK MEDICAL COLLEGE   (United States)

ⁱ DEPARTMENT OF VETERANS AFFAIRS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; CREATININE; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; POTASSIUM; SPIRONOLACTONE;

AFRICAN AMERICAN; AGED; ARTICLE; CHRONIC KIDNEY DISEASE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DRUG USE; FEMALE; GLOMERULUS FILTRATION RATE; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HOSPITAL DISCHARGE; HOSPITAL PATIENT; HOSPITAL READMISSION; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICARE; MORTALITY; POTASSIUM BLOOD LEVEL; PRESCRIPTION; PRIORITY JOURNAL; PROPENSITY SCORE; VERY ELDERLY;

AGED; ALABAMA; DIURETICS; FEMALE; GLOMERULAR FILTRATION RATE; HEART FAILURE; HUMANS; MALE; MEDICARE; PATIENT READMISSION; RISK FACTORS; SPIRONOLACTONE; STROKE VOLUME; TREATMENT OUTCOME; UNITED STATES;

EID: 84902149428     PISSN: 00029149     EISSN: 18791913     Source Type: Journal    
DOI: 10.1016/j.amjcard.2014.03.062     Document Type: Article

References (15)

1. B. Pitt, W. Remme, F. Zannad, J. Neaton, F. Martinez, B. Roniker, R. Bittman, S. Hurley, J. Kleiman, M. Gatlin Eplerenone Post-Acute Myocardial Infarction Heart Failure Efficacy and Survival Study Investigators Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction N Engl J Med 348 2003 1309 1321
2. B. Pitt, F. Zannad, W.J. Remme, R. Cody, A. Castaigne, A. Perez, J. Palensky, and J. Wittes The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators N Engl J Med 341 1999 709 717
3. F. Zannad, J.J. McMurray, H. Krum, D.J. van Veldhuisen, K. Swedberg, H. Shi, J. Vincent, S.J. Pocock, B. Pitt Group E-HS Eplerenone in patients with systolic heart failure and mild symptoms N Engl J Med 364 2011 11 21
4. O. Vardeny, D.H. Wu, A. Desai, P. Rossignol, F. Zannad, B. Pitt, S.D. Solomon RALES Investigators Influence of baseline and worsening renal function on efficacy of spironolactone in patients with severe heart failure: insights from RALES (Randomized Aldactone Evaluation Study) J Am Coll Cardiol 60 2012 2082 2089
5. R. Eschalier, J.J. McMurray, K. Swedberg, D.J. van Veldhuisen, H. Krum, S.J. Pocock, H. Shi, J. Vincent, P. Rossignol, F. Zannad, B. Pitt EMPHASIS-HF Investigators Safety and efficacy of eplerenone in patients at high risk for hyperkalemia and/or worsening renal function: analyses of the EMPHASIS-HF study subgroups (eplerenone in mild patients hospitalization and survival study in heart failure) J Am Coll Cardiol 62 2013 1585 1593
6. A.F. Hernandez, X. Mi, B.G. Hammill, S.C. Hammill, P.A. Heidenreich, F.A. Masoudi, L.G. Qualls, E.D. Peterson, G.C. Fonarow, and L.H. Curtis Associations between aldosterone antagonist therapy and risks of mortality and readmission among patients with heart failure and reduced ejection fraction JAMA 308 2012 2097 2107
7. M.A. Feller, M. Mujib, Y. Zhang, O.J. Ekundayo, I.B. Aban, G.C. Fonarow, R.M. Allman, and A. Ahmed Baseline characteristics, quality of care, and outcomes of younger and older Medicare beneficiaries hospitalized with heart failure: findings from the Alabama Heart Failure Project Int J Cardiol 162 2012 39 44
8. E.M. Williams, R.E. Katholi, and M.R. Karambelas Use and side-effect profile of spironolactone in a private cardiologist's practice Clin Cardiol 29 2006 149 153
9. E. Wrenger, R. Muller, M. Moesenthin, T. Welte, J.C. Frolich, and K.H. Neumann Interaction of spironolactone with ACE inhibitors or angiotensin receptor blockers: analysis of 44 cases BMJ 327 2003 147 149
10. K.P. Tamirisa, K.D. Aaronson, and T.M. Koelling Spironolactone-induced renal insufficiency and hyperkalemia in patients with heart failure Am Heart J 148 2004 971 978
11. C.W. Yancy, M. Jessup, B. Bozkurt, J. Butler, D.E. Casey Jr., M.H. Drazner, G.C. Fonarow, S.A. Geraci, T. Horwich, J.L. Januzzi, M.R. Johnson, E.K. Kasper, W.C. Levy, F.A. Masoudi, P.E. McBride, J.J. McMurray, J.E. Mitchell, P.N. Peterson, B. Riegel, F. Sam, L.W. Stevenson, W.H. Tang, E.J. Tsai, and B.L. Wilkoff 2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines Circulation 128 2013 e240 e319
12. J. Butler, J.A. Ezekowitz, S.P. Collins, M.M. Givertz, J.R. Teerlink, M.N. Walsh, N.M. Albert, C.A. Westlake Canary, P.E. Carson, M. Colvin-Adams, J.C. Fang, A.F. Hernandez, R.E. Hershberger, S.D. Katz, J.G. Rogers, J.A. Spertus, W.G. Stevenson, N.K. Sweitzer, W.H. Tang, W.G. Stough, and R.C. Starling Update on aldosterone antagonists use in heart failure with reduced left ventricular ejection fraction. Heart Failure Society of America Guidelines Committee J Card Fail 18 2012 265 281
13. S.F. Jencks, M.V. Williams, and E.A. Coleman Rehospitalizations among patients in the Medicare fee-for-service program N Engl J Med 360 2009 1418 1428
14. A. Ahmed, G.C. Fonarow, Y. Zhang, P.W. Sanders, R.M. Allman, D.K. Arnett, M.A. Feller, T.E. Love, I.B. Aban, R. Levesque, O.J. Ekundayo, L.J. Dell'Italia, G.L. Bakris, and M.W. Rich Renin-angiotensin inhibition in systolic heart failure and chronic kidney disease Am J Med 125 2012 399 410
15. R. Clarke, M. Shipley, S. Lewington, L. Youngman, R. Collins, M. Marmot, and R. Peto Underestimation of risk associations due to regression dilution in long-term follow-up of prospective studies Am J Epidemiol 150 1999 341 353